These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


359 related items for PubMed ID: 3029147

  • 1. Phosphorylation of regulatory subunit of type I cyclic AMP-dependent protein kinase: biphasic effects of cyclic AMP in intact S49 mouse lymphoma cells.
    Russell JL, Steinberg RA.
    J Cell Physiol; 1987 Feb; 130(2):207-13. PubMed ID: 3029147
    [Abstract] [Full Text] [Related]

  • 2. Second-site mutations in cyclic AMP-sensitive revertants of a Ka mutant of S49 mouse lymphoma cells reduce the affinity of regulatory subunit of cyclic AMP-dependent protein kinase for catalytic subunit.
    Cauthron RD, Gorman KB, Symcox MM, Steinberg RA.
    J Cell Physiol; 1995 Nov; 165(2):376-85. PubMed ID: 7593216
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells.
    Shuntoh H, Steinberg RA.
    J Cell Physiol; 1991 Jan; 146(1):86-93. PubMed ID: 1846638
    [Abstract] [Full Text] [Related]

  • 4. Interactions between cyclic AMP- and phorbol ester-dependent phosphorylation systems in S49 mouse lymphoma cells.
    Kiss Z, Steinberg RA.
    J Cell Physiol; 1985 Nov; 125(2):200-6. PubMed ID: 2997237
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate.
    Downs SM, Hunzicker-Dunn M.
    Dev Biol; 1995 Nov; 172(1):72-85. PubMed ID: 7589815
    [Abstract] [Full Text] [Related]

  • 6. A variant of S49 mouse lymphoma cells with enhanced secretion of cyclic AMP.
    Steinberg RA, Steinberg MG, van Daalen Wetters T.
    J Cell Physiol; 1979 Sep; 100(3):579-88. PubMed ID: 226556
    [Abstract] [Full Text] [Related]

  • 7. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.
    Tagliaferri P, Katsaros D, Clair T, Ally S, Tortora G, Neckers L, Rubalcava B, Parandoosh Z, Chang YA, Revankar GR.
    Cancer Res; 1988 Mar 15; 48(6):1642-50. PubMed ID: 2830966
    [Abstract] [Full Text] [Related]

  • 8. Cyclic adenosine 3',5'monophosphate/protein kinase A and mitogen-activated protein kinase 3/1 pathways are involved in adenylate cyclase-activating polypeptide 1-induced common alpha-glycoprotein subunit gene (Cga) expression in mouse pituitary gonadotroph LbetaT2 cells.
    Harada T, Kanasaki H, Mutiara S, Oride A, Miyazaki K.
    Biol Reprod; 2007 Oct 15; 77(4):707-16. PubMed ID: 17596563
    [Abstract] [Full Text] [Related]

  • 9. Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
    Thomas JM, Hoffman BB.
    Mol Pharmacol; 1989 Jan 15; 35(1):116-24. PubMed ID: 2563303
    [Abstract] [Full Text] [Related]

  • 10. M2 subunit of ribonucleotide reductase is a target of cyclic AMP-dependent protein kinase.
    Albert DA, Nodzenski E.
    J Cell Physiol; 1989 Jan 15; 138(1):129-36. PubMed ID: 2536034
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
    Albert DA, Nodzenski E, Yim G, Kowalski J.
    J Cell Physiol; 1990 May 15; 143(2):251-6. PubMed ID: 2159014
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Definition of an electrostatic relay switch critical for the cAMP-dependent activation of protein kinase A as revealed by the D170A mutant of RIalpha.
    Abu-Abed M, Das R, Wang L, Melacini G.
    Proteins; 2007 Oct 01; 69(1):112-24. PubMed ID: 17596845
    [Abstract] [Full Text] [Related]

  • 18. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase.
    Herberg FW, Taylor SS, Dostmann WR.
    Biochemistry; 1996 Mar 05; 35(9):2934-42. PubMed ID: 8608131
    [Abstract] [Full Text] [Related]

  • 19. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J, Jones JM, Nguyen-Huu X, Ten Eyck LF, Taylor SS.
    Biochemistry; 2004 Jun 01; 43(21):6620-9. PubMed ID: 15157095
    [Abstract] [Full Text] [Related]

  • 20. B16 mouse melanoma cells selected for resistance to cyclic AMP-mediated growth inhibition are cross-resistant to retinoic acid-induced growth inhibition.
    Niles RM, Loewy B.
    J Cell Physiol; 1991 Apr 01; 147(1):176-81. PubMed ID: 1645360
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.